2014 FDA Networking Safety 
Legacy MEDSearch
JUNE 27, 2022
IOPS® is FDA 510(k) cleared and currently launching in the US at select sites. “Our technology is already yielding excellent clinical benefits and this funding will help realize our mission of improving the outcomes, radiation safety and accuracy in endovascular surgery,” said Philip D.
European Pharmaceutical Review
AUGUST 23, 2022
FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. The US Food and Drug Administration (FDA) further estimates that 97 percent of online pharmacies are operating illegally. This allows for a cyber? Available from: [link].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 27, 2023
Hervé Affagard (HA): Developing microbiome therapeutics as well as every other new therapeutic modality comes with several challenges that need to be addressed carefully to ensure patient safety and maximise the potential benefits of these treatments. The plant is set to be operational before the end of 2023.
pharmaphorum
OCTOBER 26, 2022
There are many challenges in the development of therapies for rare diseases due to several unique factors, including small target patient populations, lack of long-term safety and efficacy data or natural history data, and often complex administration, dosing, and patient monitoring requirements,” Chiesi says.
Legacy MEDSearch
AUGUST 11, 2022
OSSIOfiber Suture Anchors were FDA cleared in March 2022 for use in “fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist, and elbow” in a variety of specific orthopedic procedures. This is another big step for OSSIOfiber in becoming a new material standard in orthopedic fixation.”. About OSSIO.
Expert insights. Personalized for you.
52 
Let's personalize your content